• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    3.99 Down 0.05(1.24%) Dec 19, 4:00PM EST
    |After Hours : 3.98 Down 0.01 (0.25%) Dec 19, 6:11PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 81,394   27,587   12,719  
    Cost of Revenue6,180  3,671  8,100  
    Gross Profit 75,214   23,916   4,619  
    Operating Expenses
    Research Development66,468  54,112  58,706  
    Selling General and Administrative31,681  26,226  24,248  
    Non Recurring -   -  3,467  
    Others -  691  997  
    Total Operating Expenses -   -  87,418  
    Operating Income or Loss (22,935) (57,113) (82,799)
    Income from Continuing Operations
    Total Other Income/Expenses Net10,591  (19,244)(12,116)
    Earnings Before Interest And Taxes(12,344)(70,019)(84,401)
    Interest Expense7,091  9,120  14,309  
    Income Before Tax(19,435)(79,139)(98,710)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(19,435)(85,477)(109,224)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (19,435) (85,477) (109,224)
    Preferred Stock And Other Adjustments -  (2,824)(2,260)
    Net Income Applicable To Common Shares (19,435) (88,301) (111,484)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.